Physical Activity Delays Obesity-Associated Pancreatic Ductal Adenocarcinoma in Mice and Decreases Inflammation
Valentina Pita-Grisanti,Kelly Dubay,Ali Lahooti,Niharika Badi,Olivia Ueltschi,Kristyn Gumpper-Fedus,Hsiang-Yin Hsueh,Ila Lahooti,Myrriah Chavez-Tomar,Samantha Terhorst,Sue E Knoblaugh,Lei Cao,Wei Huang,Christopher C Coss,Thomas A Mace,Fouad Choueiry,Alice Hinton,Jennifer M Mitchell,Rosemarie Schmandt,Michaela Onstad Grinsfelder,Karen Basen-Engquist,Zobeida Cruz-Monserrate
DOI: https://doi.org/10.1101/2023.01.03.521203
2023-01-04
bioRxiv
Abstract:Background & aims: Obesity is a risk factor for pancreatic ductal adenocarcinoma (PDAC), a deadly disease with limited preventive strategies. Lifestyle interventions to decrease obesity might prevent obesity-associated PDAC. Here, we examined whether decreasing obesity by increased physical activity (PA) and/or dietary changes would decrease inflammation in humans and prevent PDAC in mice. Methods: Circulating inflammatory-associated cytokines of overweight and obese subjects before and after a PA intervention were compared. PDAC pre-clinical models were exposed to PA and/or dietary interventions after obesity-associated cancer initiation. Body composition, tumor progression, growth, fibrosis, inflammation, and transcriptomic changes in the adipose tissue were evaluated. Results: PA decreased the levels of systemic inflammatory cytokines in overweight and obese subjects. PDAC mice on a diet-induced obesity (DIO) and PA intervention, had delayed weight gain, decreased systemic inflammation, lower grade pancreatic intraepithelial neoplasia lesions, reduced PDAC incidence, and increased anti-inflammatory signals in the adipose tissue compared to controls. PA had additional cancer prevention benefits when combined with a non-obesogenic diet after DIO. However, weight loss through PA alone or combined with a dietary intervention did not prevent tumor growth in an orthotopic PDAC model. Adipose-specific targeting of interleukin (IL)-15, an anti-inflammatory cytokine induced by PA in the adipose tissue, slowed PDAC growth. Conclusions: PA alone or combined with diet-induced weight loss delayed the progression of PDAC and reduced systemic and adipose inflammatory signals. Therefore, obesity management via dietary interventions and/or PA, or modulating weight loss related pathways could prevent obesity-associated PDAC in high-risk obese individuals.